JP2014501778A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501778A5
JP2014501778A5 JP2013548446A JP2013548446A JP2014501778A5 JP 2014501778 A5 JP2014501778 A5 JP 2014501778A5 JP 2013548446 A JP2013548446 A JP 2013548446A JP 2013548446 A JP2013548446 A JP 2013548446A JP 2014501778 A5 JP2014501778 A5 JP 2014501778A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cell
composition according
group
accs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013548446A
Other languages
English (en)
Japanese (ja)
Other versions
JP6041812B2 (ja
JP2014501778A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/000017 external-priority patent/WO2012096796A1/en
Publication of JP2014501778A publication Critical patent/JP2014501778A/ja
Publication of JP2014501778A5 publication Critical patent/JP2014501778A5/ja
Application granted granted Critical
Publication of JP6041812B2 publication Critical patent/JP6041812B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013548446A 2011-01-10 2012-01-07 結合組織の損傷および障害の治癒を促進する方法 Active JP6041812B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161460913P 2011-01-10 2011-01-10
US61/460,913 2011-01-10
PCT/US2012/000017 WO2012096796A1 (en) 2011-01-10 2012-01-07 Methods for accelerating the healing of connective tissue injuries and disorders

Publications (3)

Publication Number Publication Date
JP2014501778A JP2014501778A (ja) 2014-01-23
JP2014501778A5 true JP2014501778A5 (https=) 2014-12-25
JP6041812B2 JP6041812B2 (ja) 2016-12-14

Family

ID=46455423

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013548446A Active JP6041812B2 (ja) 2011-01-10 2012-01-07 結合組織の損傷および障害の治癒を促進する方法

Country Status (7)

Country Link
US (3) US8642547B2 (https=)
EP (1) EP2663637B1 (https=)
JP (1) JP6041812B2 (https=)
CN (1) CN103298927B (https=)
CA (1) CA2823689C (https=)
ES (1) ES2646438T3 (https=)
WO (1) WO2012096796A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015171880A1 (en) * 2014-05-08 2015-11-12 The University Of Florida Research Foundation, Inc. Sustained release angiogenesis modulating compositions and methods for induction and modulation of angiogenesis
JP7644564B2 (ja) * 2016-12-28 2025-03-12 ロート製薬株式会社 細胞医薬組成物、疾患治療用キット及び細胞懸濁用溶液
CN114340647A (zh) * 2019-08-09 2022-04-12 艾索洛特巴罗克有限公司 衍生自人羊膜细胞的组合物及相关方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
EP0896825B1 (en) * 1997-08-14 2002-07-17 Sulzer Innotec Ag Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors
EP2316918B1 (en) * 2001-02-14 2015-07-01 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
GB0113697D0 (en) * 2001-06-06 2001-07-25 Smith & Nephew Fixation devices for tissue repair
US7473816B2 (en) * 2004-05-18 2009-01-06 Lohmann & Rauscher, Inc. Multilayer moisture management fabric
US8153430B2 (en) 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
US20060222634A1 (en) 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
EP1981970A4 (en) 2006-01-11 2009-10-21 Technion Res & Dev Foundation TISSUE CONSTRUCTION TISSUE TREATMENT DERIVED FROM A HUMAN EMBRYONIC STEM CELL
US8871198B2 (en) * 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US8475788B2 (en) * 2006-06-14 2013-07-02 Stemnion, Inc. Methods of treating spinal cord injury and minimizing scarring
US8221741B2 (en) * 2007-01-17 2012-07-17 Marshall Vivienne S Methods for modulating inflammatory and/or immune responses
JPWO2008102568A1 (ja) * 2007-02-22 2010-05-27 株式会社Pgリサーチ 骨軟骨形成促進剤
WO2009008928A2 (en) * 2007-04-13 2009-01-15 Stemnion, Inc. Methods for treating nervous system injury and disease
US20080279825A1 (en) * 2007-05-10 2008-11-13 Malinin Theodore I Cartilage material
TR201815580T4 (tr) * 2007-08-22 2018-11-21 Noveome Biotherapeutics Inc Yaraları iyileştirmeye yönelik çözelti bileşimleri ve bunların kullanımlarını içeren yeni selüler faktör.
WO2010012025A1 (en) * 2008-07-28 2010-02-04 Monash University Amnion epithelial cells for the treatment of degenerative disc disease
US20100215731A1 (en) * 2009-02-20 2010-08-26 Maastricht University Method for improving cartilage repair and/or preventing cartilage degeneration in a joint

Similar Documents

Publication Publication Date Title
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
WO2013123215A3 (en) Antiviral drugs for treatment of arenavirus infection
JP2010507567A5 (https=)
JP2016508134A5 (https=)
JP2012041342A5 (https=)
PH12013501790B1 (en) Use of dpp iv inhibitors
JP2016507532A5 (https=)
BR112014019431A8 (pt) Método compartimentalizado de distribuição de ácido nucleico e composições e usos desses
JP2013516482A5 (https=)
IL216741A (en) History of imidazolidine-2-van 1,3-imaging modalities as 17-cyp inhibitors, pharmaceutical preparations containing them, and their use in the preparation of drugs for the treatment of diseases
MX2010002278A (es) Farmacos antivirales para el tratamiento de una infeccion por arenavirus.
JP2016517888A5 (https=)
JP2013508269A5 (https=)
JP2012107063A5 (https=)
JP2014501778A5 (https=)
BR112017018209A2 (pt) produtos terapêuticos de polipeptídeo e usos dos mesmos
CN105726513A (zh) 一种远红外消炎镇痛贴
JP2015044878A5 (https=)
JP2014501242A5 (https=)
BR112014005966A2 (pt) composições para o tratamento de úlceras periféricas de várias origens
Elliot et al. Therapeutic benefits of exosomes derived from mesenchymal stromal cells in bleomycin-induced pulmonary fibrosis in aged mice
WO2015060702A8 (en) Pharmaceutical composition for controlling body mass gain comprising s-phenotropil
WO2015027669A3 (zh) 苯基取代化合物及其药物组合物和应用
Donzelli et al. Human Mesenchymal Stem Cells and Endothelial Progenitor Cells exert a neuroprotective effect on rat cortical neurons injured by oxygen and glucose deprivation
WO2014140680A8 (en) Dosing regimen for use of celgosivir as an antiviral therapeutic for dengue virus infection